2 terminated, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Precursor B-Cell Lymphoblastic Leukemia: new trials by email Literature Review of Precursor B-Cell Lymphoblastic Leukemia trials Research Report on Precursor B-Cell Lymphoblastic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL Dexamethasone, Blinatumomab, Venetoclax - Precursor B-Cell Lymphoblastic Leukemia | Phase 2 | Recruiting | First Affiliated Hospital of Zhejiang University | 20 | 2024-08-15 | 2024-08-15 |
| Acute Lymphoblastic Leukemia Registry at Asan Medical Center Diagnosed as ALL - Leukemia, Acute Lymphoblastic, Precursor B-Cell Lymphoblastic Leukemia | Terminated | Asan Medical Center | 200 | 2013-01-01 | 2018-07-20 | |
| A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL Decitabine, Vorinostat, Vincristine - Acute Lymphoblastic Leukemia, Precursor B-Cell Lymphoblastic Leukemia | Phase 1 / Phase 2 | Terminated | Therapeutic Advances in Childhood Leukemia Consortium | 23 | 2011-12-01 | 2020-10-27 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (3) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Leukemia (1) · Leukemia, Biphenotypic, Acute (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1) · Recurrence (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Leukemia, Lymphoid (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Leukemia (2) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Dexamethasone (2) · Methotrexate (2) · pegaspargase (2) · Calcium Dobesilate (1) · Cytarabine (1) · Decitabine (1) · Inotuzumab Ozogamicin (1) · Mitoxantrone (1) · Vincristine (1) · Vorinostat (1) · blinatumomab (1) · dexamethasone 21-phosphate (1) · dexamethasone acetate (1) · merphos (1) · venetoclax (1)
Asan Medical Center (1) · First Affiliated Hospital of Zhejiang University (1) · Therapeutic Advances in Childhood Leukemia Consortium (1)
Australia (1) · China (1) · South Korea (1) · United States (1)
Dae-Young Kim, MD, PhD (1) · Michael Burke, MD (1)